A non-pharmacological approach to the treatment of urinary tract infections: case reports with Utipro® Plus

Tommaso Cai, Cristian Konstantinidis, Sam Ward

Abstract

Recurrent urinary tract infections (UTIs) can profoundly impair patients’ quality of life and carry a substantial health resource burden. Although antibiotics are the mainstay of treatment, interest is growing in identifying antibiotic-sparing alternatives. Utipro® Plus is a medical device that acts as a mechanical barrier to protect the intestinal lumen against the adherence and invasion of uropathogenic strains of Escherichia coli. It is intended for the control and prevention of UTIs caused by E. coli and other Gram-negative uropathogens. Using illustrative case reports, this review documents outcomes in three women with recurrent UTIs who were treated with Utipro® Plus in clinical practice.

Article Details

Article Type

Review

DOI

10.7573/dic.2021-2-2

Publication Dates

Accepted: ; Published: .

Citation

Cai T, Konstantinidis C, Ward S. A non-pharmacological approach to the treatment of urinary tract infections: case reports with Utipro® Plus. Drugs in Context 2021; 10: 2021-2-2. DOI: 10.7573/dic.2021-2-2

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.